Form 4 for HUM Humana
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0001062993-24-016055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-04 | 2024-09-01 | HUM | Renaudin George II | Pres, Medicare, Medicaid | M - OptEx | $0.00 | +1,241 | 10.9K | +13% | $0 |
| D | 2024-09-04 | 2024-09-01 | HUM | Renaudin George II | Pres, Medicare, Medicaid | F - Tax | $352.14 | -303 | 10.6K | -3% | -$106.7K |
| D | 2024-09-04 | 2024-09-01 | HUM | Renaudin George II | Pres, Medicare, Medicaid | M - OptEx | $0.00 | -1,241 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Humana Common | 2024-09-01 | M | A | 1,241 | $0.00 | 10,864 | D | — | — | (F9) Includes 7,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. |
| 2 | Common | Humana Common | 2024-09-01 | F | D | 303 | $352.14 | 10,561 | D | — | — | (F11) Shares disposed of represent payment for tax liability for Restricted Stock vesting occurring on 9/1/24. |
| 3 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 1,241 | $0.00 | 0 | D | — · — to — | 1,241 Humana Common | (F4) Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). (F5) Restricted stock units granted to reporting person on 9/1/2021, 100% of the award is vesting on 9/1/2024. |